BTM	N1	N2	N3	N4	N5	N6	SI1	SI2	SI3	SI4	SI5	SI6integrin cell surface interactions (I) (M1.0)	3.206	2.78	2.455	3.709	3.329	3.061	3.854	3.134	3.423	3.214	3.593	3.046extracellular matrix (I) (M2.0)	6.775	6.14	5.699	6.258	5.926	5.632	6.265	5.876	5.234	5.774	5.495	6.262extracellular matrix (II) (M2.1)	5.952	5.732	5.645	5.691	5.701	5.632	6.03	5.641	5.363	5.59	5.576	5.586extracellular matrix (III) (M2.2)	6.775	6.14	5.699	6.258	5.926	5.632	6.265	5.876	5.234	5.774	5.495	6.262regulation of signal transduction (M3)	5.399	5.052	4.696	4.846	4.924	4.988	5.49	4.894	4.647	4.929	4.701	5.019cell cycle and transcription (M4.0)	5.884	5.471	5.333	5.429	5.378	5.493	5.846	5.318	5.047	5.424	5.168	5.463cell cycle (I) (M4.1)	3.865	3.664	3.683	3.595	3.622	3.397	3.308	3.574	3.608	3.218	3.585	3.361cell cycle (II) (M4.10)	2.158	3.652	3.824	3.504	3.067	2.242	3.013	2.914	2.666	2.758	3.205	3.254mitotic cell cycle in stimulated CD4 T cells (M4.11)	4.871	4.635	4.471	4.399	4.487	4.728	4.765	4.434	4.129	4.556	4.214	4.547C-MYC transcriptional network (M4.12)	3.479	3.296	3.511	3.52	3.417	3.384	3.054	3.352	3.423	3.279	3.444	3.287cell junction (GO) (M4.13)	3.588	3.701	3.506	3.694	3.68	3.463	3.806	3.709	3.853	3.651	3.298	3.647PLK1 signaling events (M4.2)	3.441	3.194	3.098	3.116	3.073	2.995	3.096	3.178	3.318	3.257	3.144	3.121myeloid cell enriched receptors and transporters (M4.3)	2.423	2.264	1.825	2.429	1.921	1.466	1.471	2.071	1.833	2.263	1.743	1.588mitotic cell cycle in stimulated CD4 T cells (M4.5)	3.229	3.041	3.139	3.075	2.993	2.806	2.097	3.021	3.145	2.754	3.13	2.872cell division in stimulated CD4 T cells (M4.6)	4.218	3.99	4.244	3.905	3.888	3.904	3.045	3.768	3.882	3.994	4.306	3.99mitotic cell cycle (M4.7)	6.761	6.181	6.02	6.219	6.074	6.273	6.591	6.091	5.959	6.39	6.049	6.337cell division - E2F transcription network (M4.8)	2.165	2.816	2.879	2.639	2.334	2.168	2.9	2.859	2.61	3.235	2.329	2.846mitotic cell cycle in stimulated CD4 T cells (M4.9)	4.852	5	5.02	5.171	4.956	4.881	5.019	4.689	4.773	4.726	4.903	4.973regulation of antigen presentation and immune response (M5.0)	5.42	5.264	5.159	5.202	5.257	5.348	5.423	5.246	5.364	5.347	5.111	5.297T cell activation and signaling (M5.1)	5.831	5.94	5.871	5.934	5.923	5.612	5.649	5.881	6.245	5.772	5.924	5.965enriched in T cells (I) (M7.0)	4.4	4.664	4.569	4.683	4.643	4.119	4.188	4.596	4.972	4.246	4.739	4.624T cell activation (I) (M7.1)	4.203	4.4	4.334	4.381	4.424	4.026	3.995	4.36	4.699	4.096	4.487	4.325enriched in NK cells (I) (M7.2)	4.714	4.998	4.684	5.159	4.719	3.948	4.413	4.876	5.508	4.361	4.751	5.124T cell activation (II) (M7.3)	4.454	4.31	4.236	4.423	4.313	3.984	4.145	4.288	4.734	4.06	4.366	4.37T cell activation (III) (M7.4)	3.442	3.826	3.51	3.696	3.848	3.437	3.237	3.754	4.105	3.599	3.738	3.55B cell development (M9)	5.297	4.718	4.858	4.806	4.618	4.985	5.221	4.927	4.623	4.996	4.948	5.093E2F1 targets (Q3) (M10.0)	4.078	3.795	3.838	3.782	3.931	3.607	3.661	3.989	3.967	3.862	3.823	3.769E2F1 targets (Q4) (M10.1)	4.321	4.082	4.188	3.925	3.969	3.736	3.672	4.022	4.098	3.776	3.995	3.921enriched in monocytes (II) (M11.0)	5.934	5.49	5.337	5.453	5.409	5.536	5.933	5.42	5.11	5.53	5.215	5.508blood coagulation (M11.1)	6.447	6.026	5.754	5.956	5.906	5.839	6.429	5.984	5.817	6.028	5.848	6.055formyl peptide receptor mediated neutrophil response (M11.2)	7.085	6.637	6.471	6.528	6.522	6.936	7.243	6.644	6.343	6.953	6.668	6.643CD28 costimulation (M12)	3.694	3.685	3.776	3.916	3.791	3.859	3.685	3.801	3.962	3.985	3.795	3.73innate activation by cytosolic DNA sensing (M13)	5.757	4.812	5.082	4.749	4.834	5.644	5.656	4.955	4.92	4.886	5.136	4.91T cell differentiation (M14)	3.373	3.684	3.499	3.543	3.944	3.382	3.197	3.576	3.748	3.502	3.711	3.334Ran mediated mitosis (M15)	3.999	3.781	3.913	3.745	3.48	3.192	3.653	3.496	4.06	3.608	3.596	3.588TLR and inflammatory signaling (M16)	6.781	5.794	5.454	5.719	5.795	5.931	6.787	6.029	5.669	6.287	5.623	5.969T cell differentiation via ITK and PKC (M18)	3.725	4.005	3.779	3.962	4.129	3.496	3.402	3.985	4.216	3.868	3.808	3.735T cell differentiation (Th2) (M19)	3.951	3.97	3.834	3.781	4.181	3.739	3.679	3.93	4.083	3.87	4.064	3.796AP-1 transcription factor network (M20)	5.439	5.286	6.112	3.504	5.562	5.04	6.202	5.509	4.217	4.094	5.097	4.467cell adhesion (lymphocyte homing) (M21)	5.289	4.972	5.196	5.709	5.415	5.449	5.193	5.333	5.599	5.578	5.586	5.494mismatch repair (I) (M22.0)	3.362	3.106	3.015	3.056	3.159	3.022	3.026	3.255	3.21	3.142	2.821	3.099mismatch repair (II) (M22.1)	2.871	2.628	2.934	2.653	2.861	2.685	2.476	2.82	2.866	2.658	2.549	2.786"RA, WNT, CSF receptors network (monocyte) (M23)"	5.662	5.936	5.81	5.109	5.656	5.638	6.663	5.814	5.2	5.232	5.802	5.546"cell activation (IL15, IL23, TNF) (M24)"	3.733	3.337	3.378	2.988	3.262	4.15	3.922	3.149	3.137	2.905	3.366	3.146TLR8-BAFF network (M25)	5.66	4.871	4.704	4.994	4.803	5.095	5.619	4.98	4.769	5.212	4.811	4.8chemokine cluster (I) (M27.0)	5.394	6.874	5.859	5.695	6.504	5.832	6.924	6.013	5.791	4.944	6.566	5.489chemokine cluster (II) (M27.1)	5.926	5.811	5.305	5.771	5.546	5.453	6.064	5.757	5.841	5.039	5.779	5.865antigen presentation (lipids and proteins) (M28)	5.238	5.604	5.611	5.497	5.687	5.235	5.046	5.132	5.594	5.141	5.223	5.413proinflammatory cytokines and chemokines (M29)	4.569	4.807	5.231	4.156	4.029	4.959	6.214	4.68	3.706	3.563	5.343	4.13"cell movement, Adhesion & Platelet activation (M30)"	3.28	2.867	3.203	3.811	3.671	3.789	4.083	3.239	3.613	3.483	3.917	2.983cell cycle and growth arrest (M31)	5.494	5.429	5.434	4.401	5.625	5.456	6.5	5.403	4.739	4.58	5.683	5.06platelet activation (I) (M32.0)	5.443	5.364	5.437	5.161	5.285	5.292	5.375	5.298	5.189	5.319	5.479	5.331platelet activation (II) (M32.1)	5.551	5.502	5.497	5.375	5.384	5.43	5.62	5.505	5.42	5.485	5.592	5.467CORO1A-DEF6 network (I) (M32.2)	4.441	4.607	4.744	4.363	4.58	4.5	4.533	4.514	4.392	4.386	4.753	4.511KLF12 targets network (M32.3)	5.076	4.981	5.01	4.716	4.86	4.981	5.067	4.882	4.757	4.969	5.056	4.966CORO1A-DEF6 network (II) (M32.4)	4.599	4.712	4.833	4.462	4.659	4.728	4.596	4.626	4.48	4.61	4.925	4.728TBA (M32.5)	4.765	4.884	5.102	4.828	4.8	4.957	4.773	4.788	4.752	4.808	5.061	4.743TBA (M32.6)	4.931	5.016	5.044	4.874	4.889	5.065	4.934	4.909	4.735	4.895	5.114	4.822TBA (M32.7)	3.867	4.239	4.347	3.965	4.176	4.256	4.06	4.119	3.982	4.138	4.326	4.077cytoskeletal remodeling (M32.8)	5.567	5.537	5.555	5.501	5.511	5.348	5.661	5.62	5.644	5.642	5.628	5.51inflammatory response (M33)	6.965	6.319	6.203	6.156	6.231	6.63	6.727	6.114	5.948	6.275	6.239	6.451cytoskeletal remodeling (enriched for SRF targets) (M34)	4.425	3.906	4.13	4.711	4.328	4.36	4.968	4.198	4.482	4.801	4.355	4.193signaling in T cells (I) (M35.0)	4.847	4.527	6.005	3.957	4.541	4.468	5.276	5.096	4.557	3.684	5.025	4.57signaling in T cells (II) (M35.1)	4.629	4.347	4.777	4.98	3.556	3.744	4.139	4.635	4.94	3.621	4.53	4.549"T cell surface, activation (M36)"	5.873	5.588	5.599	5.41	5.465	5.445	5.59	5.377	5.881	5.431	5.188	5.636immune activation - generic cluster (M37.0)	5.203	4.701	4.638	4.74	4.752	4.836	5.195	4.825	4.518	4.869	4.518	4.681enriched in neutrophils (I) (M37.1)	6.539	6.184	5.677	5.847	6.079	5.972	7.086	6.291	5.818	6.406	5.817	6.077endoplasmic reticulum (M37.2)	5.413	4.975	4.677	4.975	4.739	5.113	5.414	5.003	4.623	5.174	4.533	4.857cell division (M37.3)	2.632	2.75	2.67	2.695	2.552	2.393	2.126	2.51	2.771	2.526	2.138	2.31chemokines and receptors (M38)	5.163	5.565	5.42	5.109	5.21	5.287	5.932	5.102	5.17	4.616	5.498	5.026integrin mediated leukocyte migration (M39)	5.703	5.516	5.149	5.402	5.44	5.199	5.431	5.555	5.631	5.498	5.224	5.5complement and other receptors in DCs (M40)	6.269	6.032	5.718	5.921	5.9	6.048	6.278	5.898	5.898	6.244	5.683	6.169platelet activation (III) (M42)	5.892	5.263	5.021	5.24	5.27	5.441	5.861	5.417	5.357	5.687	5.251	5.444"myeloid, dendritic cell activation via NFkB (I) (M43.0)"	3.889	3.791	3.87	3.61	3.849	4.167	4.373	3.755	3.783	3.711	3.967	3.822"myeloid, dendritic cell activation via NFkB (II) (M43.1)"	5.343	4.934	4.932	4.931	5.108	5.25	5.542	4.944	4.863	5.035	5.125	5.109T cell signaling and costimulation (M44)	7.285	6.972	6.874	6.938	7.009	6.798	7.129	7.02	6.978	7.026	6.963	6.993leukocyte activation and migration (M45)	6.259	6.07	5.923	6.092	6.072	5.897	6.069	6.024	6.315	5.946	6.016	6.107cell division (stimulated CD4+ T cells) (M46)	4.391	3.876	4.066	3.775	3.549	3.908	4.126	3.989	3.208	4.173	3.747	3.667enriched in B cells (I) (M47.0)	2.151	3.292	3.634	3.066	3.88	3.665	2.96	3.762	4.155	4.029	3.567	3.662enriched in B cells (II) (M47.1)	2.679	3.237	3.772	3.158	3.806	3.842	3.085	3.855	3.917	4.154	3.391	3.578enriched in B cells (III) (M47.2)	3.863	3.959	4.208	4.053	4.289	4.272	3.896	4.15	4.253	4.311	4.002	4.073enriched in B cells (IV) (M47.3)	2.974	3.048	3.273	2.93	3.301	3.134	3.015	3.255	3.284	3.452	3.027	2.995enriched in B cells (V) (M47.4)	3.686	3.866	4.181	4	4.438	3.927	3.964	4.118	4.183	4.323	3.965	3.962TBA (M48)	6.224	5.876	5.701	5.71	5.728	5.803	6.15	5.899	5.684	5.94	5.861	6.051transcription regulation in cell development (M49)	5.251	5.164	4.903	5.208	4.977	5.352	5.335	5	4.896	5.283	4.983	5.124CD1 and other DC receptors (M50)	4.866	4.68	4.722	4.913	4.552	4.34	5.207	4.88	4.528	4.998	4.821	4.451cell adhesion (M51)	3.734	3.643	3.626	3.865	3.88	3.991	4.662	3.534	3.605	3.202	4.006	3.229T cell activation (IV) (M52)	6.705	6.445	6.37	6.308	6.46	6.512	6.534	6.502	6.526	6.459	6.492	6.443inflammasome receptors and signaling (M53)	4.716	4.277	3.944	4.124	4.146	4.537	4.69	4.025	3.852	4.133	4.046	4.045BCR signaling (M54)	5.789	5.528	5.476	5.485	5.537	5.497	5.846	5.665	5.643	5.917	5.452	5.605TBA (M55)	6.912	6.323	6.183	6.212	6.268	6.142	7.016	6.238	6.085	6.522	6.45	6.45suppression of MAPK signaling (M56)	6.127	5.895	5.929	5.519	5.715	5.846	6.936	5.839	5.48	5.913	6.134	5.873"immuregulation - monocytes, T and B cells (M57)"	3.133	3.699	4.137	3.059	4.364	3.827	4.301	4.099	3.882	2.835	4.419	3.863B cell development/activation (M58)	4.852	4.828	4.714	4.571	4.892	4.999	5.175	4.957	4.824	5.092	4.771	4.701"CCR1, 7 and cell signaling (M59)"	5.937	5.061	4.851	5.073	5.176	5.462	5.881	5.47	5.126	5.009	5.305	5.375lymphocyte generic cluster (M60)	2.773	3.205	3.065	3.048	3.254	2.671	2.751	3.297	3.314	3.535	2.934	3.121enriched in NK cells (II) (M61.0)	4.244	4.704	4.773	5.074	4.585	3.803	4.167	4.752	5.222	4.129	4.806	4.897enriched in NK cells (receptor activation) (M61.2)	3.789	4.273	3.858	4.378	4.093	3.49	3.69	4.306	4.712	3.674	4.189	4.298"T & B cell development, activation (M62.0)"	3.099	3.452	3.588	3.176	3.88	3.542	3.233	3.731	3.844	3.398	3.812	3.531regulation of localization (GO) (M63)	5.106	5.165	5.211	4.934	4.972	5.217	5.048	4.999	4.932	5.019	5.221	5.024enriched in activated dendritic cells/monocytes (M64)	5.94	6.061	5.641	5.349	5.88	6.08	6.841	5.909	5.477	5.53	5.759	5.58"IL2, IL7, TCR network (M65)"	5.344	5.313	5.316	5.298	5.543	5.234	5.219	5.455	5.414	5.381	5.786	5.45TBA (M66)	5.464	5.148	5.175	5.242	5.135	5.251	5.218	5.005	4.712	5.015	4.79	5.171activated dendritic cells (M67)	5.814	3.461	3.095	2.937	3.321	5.357	4.019	3.456	3.499	3.035	2.979	2.943RIG-1 like receptor signaling (M68)	5.332	4.307	4.379	3.748	4.035	5.489	4.932	4.175	3.91	3.678	4.27	3.872enriched in B cells (VI) (M69)	2.243	3.477	3.858	3.195	4.036	3.784	3.048	3.814	4.278	4.093	3.75	3.818TBA (M70.0)	3.984	3.409	3.445	3.284	3.821	3.979	4.371	3.699	3.28	3.974	4.393	3.975TBA (M70.1)	4.976	4.523	4.429	4.478	4.444	4.639	5.249	4.585	4.482	4.969	4.626	4.732enriched in antigen presentation (I) (M71)	4.892	5.607	5.527	5.226	5.44	5.614	5.459	5.114	5.207	5.226	5.142	5.365TBA (M72.0)	4.116	3.934	3.636	3.906	3.921	3.859	3.999	4.152	4.08	4.065	3.481	3.946TBA (M72.1)	4.457	4.327	3.953	4.247	4.248	4.185	4.393	4.424	4.384	4.397	3.897	4.227TBA (M72.2)	4.505	4.32	3.912	4.231	4.318	4.132	4.522	4.502	4.32	4.445	3.797	4.206enriched in monocytes (III) (M73)	5.557	5.122	4.871	4.711	5.063	5.263	5.935	5.282	4.73	4.874	4.841	5.08transcriptional targets of glucocorticoid receptor (M74)	3.869	4.167	4.536	4.249	4.454	4.109	4.013	4.442	4.38	4.376	4.17	4.073antiviral IFN signature (M75)	5.839	3.753	3.479	3.301	3.62	5.34	4.426	3.858	3.697	3.568	3.368	3.294DNA repair (M76)	2.992	2.588	2.939	2.938	2.84	2.802	2.918	2.897	2.943	2.928	2.837	2.944"collagen, TGFB family et al (M77)"	3.123	3.059	3.351	3.534	3.631	3.639	3.523	3.519	3.429	3.394	4.086	3.424"myeloid cell cytokines, metallopeptidases and laminins (M78)"	6.845	5.196	5.165	5.366	5.001	5.778	5.843	5.417	4.764	5.407	5.517	5.375TBA (M79)	5.643	5.292	4.793	5.15	5.036	5.219	5.631	5.282	4.942	5.374	4.499	4.955TBA (M80)	3.556	3.232	3.376	3.696	3.798	3.775	3.569	3.694	3.811	4.038	3.692	3.499enriched in myeloid cells and monocytes (M81)	4.974	4.564	4.161	4.836	4.756	4.762	5.298	4.593	4.608	4.837	4.526	4.559enriched in naive and memory B cells (M83)	3.831	4.299	4.793	4.455	4.785	4.492	4.361	4.903	4.683	4.988	4.326	4.407integrins and cell adhesion (M84)	6.626	6.573	6.38	6.441	6.386	6.392	6.722	6.627	6.63	6.619	6.386	6.634platelet activation and degranulation (M85)	6.067	5.391	5.265	6.323	5.954	5.735	6.381	5.789	6.12	5.84	6.104	5.598chemokines and inflammatory molecules in myeloid cells (M86.0)	4.845	4.92	4.745	4.248	4.789	5.045	5.479	4.77	4.509	4.078	4.771	4.556"proinflammatory dendritic cell, myeloid cell response (M86.1)"	4.287	3.942	4.058	4.125	3.781	4.525	4.698	4.127	3.971	3.612	4.163	4.031transmembrane transport (I) (M87)	5.223	4.963	4.464	4.897	4.754	4.934	5.361	4.709	4.67	5.027	4.434	4.875leukocyte migration (M88.0)	4.443	3.212	3.088	3.613	3.372	3.906	3.65	3.184	3.402	3.112	3.177	3.003enriched in hepatocyte nuclear factors (II) (M88.2)	2.696	3.015	3.196	2.638	3.141	3.071	2.932	2.646	2.701	2.716	2.883	2.819putative targets of PAX3 (M89.0)	2.638	4.235	5.117	1.617	4.962	4.618	4.602	3.858	3.152	1.422	3.839	2.17putative targets of PAX3 (M89.1)	2.881	4.667	5.13	2.641	5.122	4.993	4.715	4.268	4.062	2.342	4.526	3.532"adhesion and migration, chemotaxis (M91)"	6.207	6.078	5.186	6.111	5.756	5.362	6.013	5.719	6.073	5.901	5.701	5.986"lipid metabolism, endoplasmic reticulum (M92)"	4.366	4.46	4.193	4.166	4.295	4.431	4.974	4.377	3.519	4.109	3.912	4.218TBA (M93)	2.953	2.141	2.921	1.824	2.203	2.618	3.89	2.515	1.301	1.22	3.124	2.675"growth factor induced, enriched in nuclear receptor subfamily 4 (M94)"	5.289	4.974	5.91	4.733	5.514	5.625	6.395	5.359	5.27	5.106	5.658	5.319enriched in antigen presentation (II) (M95.0)	7.123	7.046	6.755	6.95	6.928	6.957	6.965	6.894	6.987	7.083	6.52	6.874enriched in antigen presentation (III) (M95.1)	7.543	7.661	7.332	7.414	7.538	7.676	7.589	7.356	7.576	7.585	7.045	7.354enriched for SMAD2/3 signaling (M97)	3.475	4.082	3.756	3.413	4.297	3.842	4.171	4.664	4.29	4.711	3.739	4.232"MAPK, RAS signaling (M100)"	5.782	5.81	5.799	5.651	5.74	5.759	5.846	5.81	5.721	5.759	5.966	5.759phosphatidylinositol signaling system (M101)	3.899	3.718	3.52	3.67	3.707	3.727	3.838	3.922	3.757	3.919	3.445	3.831TBA (M102)	3.21	3.804	4.764	3.901	4.474	4.032	3.427	4.369	4.86	4.758	4.378	4.13cell cycle (III) (M103)	3.671	3.421	3.637	3.618	3.52	3.531	3.434	3.627	3.658	3.567	3.553	3.477TBA (M104)	4.267	5.837	4.032	4.783	5.051	4.557	4.572	4.384	4.315	4.607	4.512	3.953TBA (M105)	4.776	3.987	3.567	4.082	4.082	4.328	4.756	3.964	3.624	3.921	3.639	3.643nuclear pore complex (M106.0)	3.12	3.245	3.087	3.431	3.255	2.986	2.947	3.154	3.315	3.139	3.219	3.192nuclear pore complex (mitosis) (M106.1)	2.555	2.707	2.572	3.03	2.769	2.562	2.72	2.707	2.825	2.833	2.817	2.856"receptors, cell migration (M109)"	5.362	4.984	4.667	4.949	4.935	4.842	5.001	5.026	4.843	4.871	4.989	4.991axon guidance (M110)	3.515	3.7	3.787	3.778	3.384	3.1	3.035	2.735	3.756	2.948	3.537	4.062viral sensing & immunity; IRF2 targets network (I) (M111.0)	6.026	5.175	5.339	5.271	5.154	6.083	5.446	5.246	5.085	5.376	5.069	5.129viral sensing & immunity; IRF2 targets network (II) (M111.1)	6.933	5.436	5.467	5.396	5.491	6.99	6.056	5.701	5.58	5.778	5.457	5.441complement activation (I) (M112.0)	6.561	4.879	4.354	4.509	4.659	4.93	5.29	4.515	4.775	4.615	4.697	4.508complement activation (II) (M112.1)	4.307	3.598	3.087	5.13	4.644	4.224	4.789	3.775	4.719	3.976	4.793	3.542golgi membrane (I) (M113)	4.272	4.056	3.486	3.762	3.621	4.245	4.497	4.006	3.612	3.988	3.223	3.892TBA (M114.0)	4.595	3.986	3.767	4.147	3.989	4.005	4.512	4.153	3.689	4.37	3.54	4.098glycerophospholipid metabolism (M114.1)	4.485	3.453	3.294	3.596	3.513	3.988	4.311	3.929	3.507	4.14	3.548	3.686cytokines - recepters cluster (M115)	3.459	2.986	2.861	3.198	3.397	3.551	3.425	2.988	2.855	2.493	2.899	2.895cell adhesion (GO) (M117)	5.197	5.309	5.216	5.263	5.335	5.203	5.216	5.217	5.408	5.208	5.297	5.119enriched in monocytes (IV) (M118.0)	5.921	5.316	5.011	5.229	5.216	5.333	5.964	5.44	5.037	5.549	5.073	5.368enriched in monocytes (surface) (M118.1)	5.456	4.818	4.641	4.953	4.82	5.074	5.517	4.932	4.427	5.302	4.757	5.085enriched in activated dendritic cells (I) (M119)	4.502	4.333	4.137	3.837	4.549	4.676	4.809	4.19	4.219	4.153	3.849	4.033TBA (M120)	5.54	5.665	5.55	5.394	5.642	5.502	5.67	5.601	5.482	5.539	5.739	5.629TBA (M121)	4.603	4.061	3.936	4.061	4.139	4.468	4.131	4.1	4.151	3.734	3.766	4.03enriched in B cell differentiation (M123)	2.472	3.595	3.554	3.079	3.72	3.052	2.499	3.064	3.119	2.562	3.379	2.806enriched in membrane proteins (M124)	5.203	4.655	4.492	5.734	4.857	5.778	5.079	4.784	4.86	5.051	4.42	4.563TBA (M125)	3.174	2.32	2.553	2.255	3.173	3.269	3.572	2.954	2.356	3.088	3.684	3.163double positive thymocytes (M126)	3.92	3.909	4.048	4.082	4.294	3.74	3.854	3.971	3.952	3.84	4.223	3.854type I interferon response (M127)	6.879	4.633	4.222	4.121	4.278	6.48	5.223	4.687	4.569	4.436	3.933	4.085TBA (M128)	3.882	3.862	3.521	3.855	3.829	3.646	3.799	3.998	3.968	3.886	3.53	3.887inositol phosphate metabolism (M129)	3.416	3.215	2.884	3.029	3.085	3.244	3.336	3.398	3.18	3.397	2.72	3.035enriched in G-protein coupled receptors (M130)	3.366	3.832	3.732	4.417	3.722	3.075	3.591	3.662	4.292	3.904	3.811	4.142TBA (M131)	4.458	3.968	3.473	3.924	3.73	4.637	4.456	3.817	3.649	3.98	3.795	3.364recruitment of neutrophils (M132)	7.166	6.696	6.274	6.406	6.623	6.674	7.62	6.98	6.449	7.04	6.685	6.862"cell adhesion, membrane (M133.0)"	1.366	2.236	2.766	2.695	2.032	2.128	2.541	2.379	1.55	2.643	2.964	2.176"Membrane, ER proteins (M134)"	2.396	2.486	2.393	2.352	2.788	2.558	2.587	2.615	2.733	3.188	2.261	2.878TBA (M136)	4.939	4.773	4.908	4.641	4.601	4.979	4.661	4.641	4.564	4.651	4.847	4.641TBA (M137)	3.22	3.148	2.905	3.227	3.211	3.167	3.158	3.399	3.253	3.228	2.707	3.155enriched for ubiquitination (M138)	3.285	3.37	3.131	3.411	3.4	3.301	2.989	3.488	3.438	3.315	2.996	3.317lysosomal/endosomal proteins (M139)	6.331	6.044	6.024	6.129	5.942	6.136	6.228	5.939	5.566	6.057	5.785	6.12"extracellular matrix, complement (M140)"	6.639	5.752	5.89	5.769	5.57	5.703	5.941	5.943	5.046	5.933	5.324	5.698TBA (M141)	3.933	2.75	2.711	2.723	2.843	3.86	3.382	2.946	2.818	2.532	2.309	2.414"nuclear pore, transport; mRNA splicing, processing (M143)"	2.779	3.201	3.164	3.374	3.207	3.074	3.005	3.139	3.231	3.22	3.147	3.21"cell cycle, ATP binding (M144)"	4.38	4.184	4.023	4.227	4.152	4.124	4.211	4.275	4.311	4.219	3.915	4.164cytoskeleton/actin (SRF transcription targets) (M145.0)	3.793	3.194	3.038	3.736	3.699	3.319	4.329	3.351	3.387	3.984	3.526	3.467cytoskeleton/actin (SRF transcription targets) (M145.1)	3.242	2.713	2.627	3.85	3.501	3.339	4.088	3.105	3.693	3.67	3.806	3.53MHC-TLR7-TLR8 cluster (M146)	7.484	7.64	7.828	7.517	7.531	7.847	7.462	7.445	7.647	7.737	7.358	7.517intracellular transport (M147)	3.771	3.741	3.51	3.725	3.701	3.591	3.752	3.842	3.828	3.836	3.385	3.633TBA (M148)	3.677	3.583	3.311	3.285	3.64	3.552	3.642	3.783	3.652	3.71	2.907	3.402innate antiviral response (M150)	6.487	4.324	3.839	3.698	3.911	5.847	4.844	4.316	4.102	4.257	3.306	3.963TBA (M151)	2.988	3.71	3.234	3.345	3.613	2.935	2.835	3.419	3.771	3.139	3.247	3.167TBA (source: B cells) (M152.0)	5.675	5.18	4.786	4.76	4.74	5.69	6.04	5.277	4.841	5.544	4.948	4.749TBA (source: naive B cells) (M152.1)	4.828	4.797	4.341	4.543	4.495	4.877	5.157	4.435	4.611	4.573	4.613	4.68TBA (source: memory B cells) (M152.2)	5.675	5.18	4.786	4.76	4.74	5.69	6.04	5.277	4.841	5.544	4.948	4.749TBA (M153)	3.563	3.465	3.169	3.452	3.477	3.377	3.298	3.465	3.493	3.522	3.06	3.391G protein coupled receptors cluster (M155)	6.32	5.859	5.223	5.49	5.463	5.472	6.062	5.705	5.519	5.725	5.561	5.682"plasma cells & B cells, immunoglobulins (M156.0)"	4.763	4.583	4.884	4.181	4.315	4.243	3.355	4.427	4.88	4.687	4.437	4.434"plasma cells, immunoglobulins (M156.1)"	5.753	4.685	4.982	3.903	3.873	4.032	2.637	4.304	4.521	4.426	4.08	4.324enriched in NK cells (III) (M157)	3.315	3.479	3.611	3.721	3.436	3.196	3.55	3.563	3.853	3.449	3.647	3.692G protein mediated calcium signaling (M159)	4.393	3.915	3.64	4.282	4.406	4.458	4.764	4.199	4.107	4.489	4.585	4.126leukocyte differentiation (M160)	4.974	5.02	4.895	4.491	5.142	5.085	5.719	5.107	4.918	4.894	5.148	4.978TBA (M161)	3.598	3.59	3.224	3.504	3.552	3.975	3.617	3.612	3.605	3.87	3.032	3.416"plasma membrane, cell junction (M162.0)"	1.366	2.236	2.766	2.695	2.032	2.128	2.541	2.379	1.55	2.643	2.964	2.176enriched in neutrophils (II) (M163)	5.346	5.011	4.925	5.068	4.922	5.251	5.944	5.396	5.009	5.741	4.965	5.352enriched in activated dendritic cells (II) (M165)	5.599	4.234	3.894	4.103	4.105	5.38	4.99	4.256	4.098	4.363	3.819	3.948enriched in cell cycle (M167)	3.987	4.341	4.075	4.493	4.213	4.946	4.282	4.216	4.325	4.538	4.251	4.208enriched in dendritic cells (M168)	4.838	4.458	4.156	4.316	4.406	4.572	4.738	4.272	4.037	4.319	4.008	4.03mitosis (TF motif CCAATNNSNNNGCG) (M169)	3.403	3.199	3.089	3.21	3.141	3.159	2.702	3.311	3.309	3.179	3.044	3.119heme biosynthesis (I) (M171)	2.557	3.288	2.494	3.87	3.265	4.506	3.163	3.107	3.573	3.899	3.412	2.823erythrocyte differentiation (M173)	2.25	2.993	2.667	3.509	2.894	4.682	2.862	2.707	2.887	3.873	2.717	2.702TBA (M174)	3.869	3.921	3.755	3.882	3.93	3.854	3.685	4	4.011	3.836	3.613	3.871TBA (M177.0)	4.323	3.837	3.698	4.355	3.803	3.901	4.17	4.104	4.168	4.233	3.669	4.24TBA (M177.1)	5.441	4.726	4.138	5.361	4.218	4.113	4.804	4.601	4.766	4.912	4.133	5.033enriched for promoter motif NATCACGTGAY (putative SREBF1 targets) (M178)	1.901	2.289	2.485	2.39	2.825	2.721	2.189	2.448	2.448	2.555	2.657	2.197enriched for TF motif PAX3 (M179)	3.489	3.55	3.317	3.47	3.734	3.598	3.413	3.766	3.531	3.489	3.349	3.564TBA (M180)	3.943	3.685	3.36	3.571	3.682	3.655	3.878	3.847	3.804	3.965	3.095	3.54nucleotide metabolism (M181)	2.867	2.626	2.832	3.056	2.815	2.868	2.1	2.61	2.865	2.48	2.554	2.684enriched in DNA interacting proteins (M182)	3.433	3.207	3.186	3.228	3.102	2.876	2.699	3.003	3.142	3.073	3.127	2.893TBA (M183)	3.969	2.289	1.836	2.723	2.636	2.852	2.8	3.2	2.726	2.763	2.157	2.737TBA (M184.0)	2.777	3.08	3.039	2.764	3.263	3.926	3.544	3.134	2.746	3.278	3.557	3.009TBA (M185)	3.49	3.298	3.241	3.194	3.348	3.222	3.314	3.312	3.422	3.403	2.981	3.238TBA (M186)	4.011	3.955	3.841	3.693	4.315	4.654	4.601	4.09	3.589	4.255	5.127	4.253TBA (M188)	2.85	3.24	2.698	2.887	3.098	2.65	2.149	3.221	3.041	2.953	2.728	2.823TBA (M190)	4.218	3.849	3.844	3.701	4.108	3.928	4.239	4.074	3.849	3.567	4.074	3.915transmembrane transport (II) (M191)	2.917	3.09	2.867	3.11	3.099	2.887	2.838	3.134	3.24	3.027	2.779	2.946TBA (M192)	5.351	5.045	5.121	4.957	4.922	5.191	5.151	4.977	4.832	5.11	5.09	4.93TBA (M193)	3.213	3.607	3.079	4.172	3.297	5.56	4.068	3.123	3.736	4.467	4.022	2.894TBA (M194)	3.279	3.278	3.034	3.37	3.243	3.05	3.083	3.394	3.26	3.289	2.976	3.175platelet activation - actin binding (M196)	3.134	2.737	2.752	3.912	3.355	3.43	3.842	2.968	3.491	3.266	3.464	2.799TBA (M198)	5.939	5.777	5.593	5.638	5.702	5.583	6.494	5.755	5.573	6.136	5.712	5.842platelet activation & blood coagulation (M199)	2.9	2.494	2.427	3.543	3.424	3.048	3.852	2.835	3.26	2.75	3.43	2.439antigen processing and presentation (M200)	4.307	4.763	4.968	4.808	4.759	4.919	4.456	4.476	4.323	4.423	4.53	3.888TBA (M201)	0.354	2.191	1.396	2.707	2.33	3.931	1.619	1.79	2.065	2.638	2.1	1.625TBA (M203)	2.367	2.766	2.48	2.629	2.897	2.738	2.542	2.865	2.833	2.989	2.242	2.608chaperonin mediated protein folding (I) (M204.0)	4.317	4.24	4.329	4.459	4.302	4.15	4.022	4.249	4.37	4.131	4.206	4.303chaperonin mediated protein folding (II) (M204.1)	4.948	4.947	5.022	5.097	4.989	4.89	4.789	4.925	5.167	4.884	4.95	4.987TBA (M205)	3.26	3.233	2.954	3.057	3.25	3.147	3.069	3.326	3.26	3.365	2.599	3.003TBA (M208)	3.912	4.572	4.186	4.268	4.326	3.849	4.346	4.238	4.281	4.141	3.628	3.882lysosome (M209)	5.661	5.146	5.128	5.463	4.91	5.4	5.243	4.975	4.868	5.16	4.819	5.27"extracellular matrix, collagen (M210)"	7.499	6.907	7.109	7.373	7.237	6.912	7.98	7.125	7.285	7.38	7.27	7.677TBA (M211)	4.29	4.409	4.193	4.348	4.465	4.239	4.113	4.487	4.589	4.305	4.112	4.212purine nucleotide biosynthesis (M212)	3.309	3.509	3.69	3.67	3.681	3.504	2.863	3.466	3.562	3.129	3.631	3.689"regulation of transcription, transcription factors (M213)"	3.865	3.779	3.318	3.813	3.721	3.608	3.981	3.912	3.882	3.962	3.452	3.782TBA (M214)	4.473	4.129	3.743	3.89	4.068	3.953	4.423	4.284	4.096	4.342	3.519	4.02small GTPase mediated signal transduction (M215)	6.524	6.453	6.326	6.225	6.339	6.32	6.751	6.447	6.266	6.508	6.429	6.556respiratory electron transport chain (mitochondrion) (M216)	5.078	5.284	5.463	5.28	5.324	5.403	4.651	4.947	5.112	4.977	5.453	5.282TBA (M218)	2.642	2.505	2.422	2.804	2.275	2.437	2.142	2.414	2.423	2.854	2.237	2.57respiratory electron transport chain (mitochondrion) (M219)	5.282	5.426	5.718	5.461	5.482	5.431	5.03	5.176	5.271	5.15	5.507	5.322TBA (M220)	2.546	1.994	2.46	4.555	0.808	2.031	3.694	3.034	3.178	3.764	2.196	2.635heme biosynthesis (II) (M222)	3.398	3.764	3.467	3.754	3.539	3.696	3.407	3.341	3.557	3.7	3.703	3.251enriched in T cells (II) (M223)	3.994	4.329	4.146	4.566	4.235	3.474	3.821	4.436	4.868	4.226	4.196	4.595proteasome (M226)	4.588	4.267	4.362	4.516	4.251	4.535	3.978	4.223	4.419	4.055	4.266	4.257translation initiation (M227)	3.775	3.581	3.843	3.775	3.707	3.711	3.358	3.764	3.471	3.437	3.449	3.66TBA (M229)	3.113	3.337	3.085	3.127	3.172	3	2.935	3.095	3.202	2.955	2.905	3.202"cell cycle, mitotic phase (M230)"	2.722	2.71	2.571	2.631	2.941	2.484	2.652	2.916	2.825	2.784	2.647	2.534respiratory electron transport chain (mitochondrion) (M231)	4.851	4.775	5.222	5.061	4.943	4.899	4.672	4.811	4.81	4.693	4.944	4.894enriched for TF motif TNCATNTCCYR (M232)	3.034	3.07	3.19	3.21	2.926	3.308	3.045	3.039	3.128	3.133	3.059	3.073"transcription elongation, RNA polymerase II (M234)"	4.177	4.481	4.859	4.105	4.407	4.685	4.122	4.232	4.216	4.214	4.903	4.42mitochondrial cluster (M235)	2.716	2.585	2.89	2.912	2.79	2.489	2.387	2.66	2.811	2.487	2.78	2.782TBA (M236)	3.966	3.448	3.384	3.895	3.327	3.547	3.47	3.509	3.743	3.845	3.572	3.707golgi membrane (II) (M237)	3.199	3.118	2.663	3.068	2.909	3.103	3.18	3.056	2.881	3.241	2.633	2.999respiratory electron transport chain (mitochondrion) (M238)	4.481	4.753	5.045	4.736	4.767	4.893	4.67	4.495	4.703	4.474	4.816	4.546TBA (M241)	3.418	3.86	3.473	3.917	3.643	3.8	3.678	3.76	3.843	3.785	3.8	3.916TBA (M242)	3.515	3.581	3.132	3.367	3.489	3.445	3.604	3.555	3.391	3.737	2.94	3.313TBA (M243)	4.717	4.765	5.097	4.751	4.704	5.009	4.716	4.752	4.478	4.737	5.115	4.698translation initiation factor 3 complex (M245)	5.682	6.226	6.388	6.2	6.189	5.99	5.613	6.092	6.156	5.893	6.049	6.063enriched in nuclear pore complex interacting proteins (M247)	3.632	3.934	3.549	4.064	3.802	3.941	3.963	3.398	3.968	3.484	3.796	4.146TBA (M248)	2.176	2.627	3.076	2.676	2.846	3.144	2.723	2.671	2.35	2.545	3.421	2.904TBA (M249)	4.082	4.055	3.705	4.314	4.149	4.311	4.147	3.939	3.941	4.313	3.448	3.508spliceosome (M250)	4.038	4.267	4.558	4.231	4.306	4.233	3.778	4.005	4.154	4.039	4.346	4.162T cell surface signature (S0)	4.029	3.981	3.969	3.806	4.214	3.833	3.766	4.002	4.183	3.924	4.212	3.921NK cell surface signature (S1)	4.442	4.05	3.867	4.387	3.699	3.609	4	4.086	4.547	4.054	3.944	4.339B cell surface signature (S2)	3.567	4.366	4.673	4.383	4.653	4.728	4.125	4.607	4.689	4.772	4.411	4.418Plasma cell surface signature (S3)	3.85	3.579	3.724	3.523	3.726	3.943	3.598	3.655	3.515	3.532	3.874	3.546Monocyte surface signature (S4)	5.682	5.284	5.054	5.299	5.194	5.18	5.937	5.311	5.019	5.485	5.123	5.32DC surface signature (S5)	3.983	3.484	3.43	3.501	3.777	4.161	3.992	3.596	3.689	3.796	3.666	3.691CD4 T cell surface signature Th1-stimulated (S6)	1.043	2.504	1.696	2.383	2.639	3.807	1.029	1.912	1.763	2.998	2.378	2.206CD4 T cell surface signature Th2-stimulated (S7)	3.671	3.435	3.255	3.114	3.773	3.105	3.273	3.588	3.642	3.522	3.607	3.366Naive B cell surface signature (S8)	3.755	4.432	4.466	4.156	4.626	4.796	4.277	4.482	4.783	4.426	4.59	4.247Memory B cell surface signature (S9)	5.431	5.263	5.861	5.2	4.957	5.404	4.791	5.644	5.256	5.583	5.63	5.143Resting dendritic cell surface signature (S10)	4.298	3.951	3.94	4.047	3.969	4.103	4.214	4.031	3.805	3.993	3.985	3.952Activated (LPS) dendritic cell surface signature (S11)	4.915	4.189	3.973	4.207	4.261	4.816	4.907	4.479	4.219	4.636	4.005	4.314targets of FOSL1/2 (M0)	6.287	6.543	5.988	4.661	6.072	5.769	6.508	5.936	4.246	4.222	5.619	4.528